tiprankstipranks

Ali Behbahani Insider Profile

11 Followers
Ali Behbahani, Director at Nevro Corp, holds 6.69M shares in Monte Rosa Therapeutics (Ticker: GLUE), holds 4.55M shares in Black Diamond Therapeutics (Ticker: BDTX), holds 0.00 shares in Arcellx Inc (Ticker: ACLX).
tipranks
Ali Behbahani

Ali Behbahani
Nevro Corp (NVRO)
Director

Ranked #101,543 out of 108,198 Corporate Insiders

Profitable Transactions

24%
5 out of 21 Profitable Transactions

Average Return

-24.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1B
22.68%
18.80%
17.69%
13.43%
27.40% Others
A breakdown of Ali Behbahani's holdings

Insider Roles

Mirum Pharmaceuticals
(MIRM)
Ten Percent Owner
MBX Biosciences, Inc.
(MBX)
Ten Percent Owner
Trevi Therapeutics
(TRVI)
Ten Percent Owner
Monte Rosa Therapeutics
(GLUE)
Director
+10 other positions
Roles that Ali Behbahani holds in companies

Most Profitable Insider Trade

Stock:
Mirum Pharmaceuticals
(MIRM)
Rating:Informative Buy
Date:Jul 24, 2019 - Jul 24, 2020
Return:+47.80%
The most profitable trade made by Ali Behbahani

Ali Behbahani's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NVRO
Nevro Corp
May 23, 2018
Uninformative Buy
$31.48K
Adaptimmune Therapeutics
Aug 19, 2025
Director
Informative Sell
195.00K
$0.00
Genocea Biosciences
May 26, 2022
Director, Ten Percent Owner
Informative Sell
711.52K
Crispr Therapeutics AG
Aug 14, 2020
Director
Uninformative Buy
$13.87K
RGLS
Regulus
May 09, 2019
Informative Buy
1.23M
$16.75M
Trevi Therapeutics
Apr 13, 2022
Ten Percent Owner
Informative Buy
6.80M
$206.32M
Mirum Pharmaceuticals
Jun 15, 2023
Ten Percent Owner
Uninformative Buy
$264.55M
Black Diamond Therapeutics
Jun 22, 2026
Director
Uninformative Buy
14.88K
$8.24M
OYST
Oyster Point Pharma
Jan 04, 2023
Uninformative Sell
$0.00
AKUS
AKOUOS
Dec 02, 2022
Uninformative Sell
$0.00
Nkarta
Director
MTCR
Metacrine
Dec 27, 2021
Informative Sell
493.91K
$1.49M
Monte Rosa Therapeutics
Jul 06, 2026
Director
Uninformative Buy
$156.67M
CVRx
Dec 18, 2023
Director
Uninformative Buy
72.68
$1.67K
NEUE
NeueHealth Inc
Oct 06, 2025
Uninformative Buy
6.81K
$0.00
Minerva Surgical
Jun 14, 2022
Director
Uninformative Buy
120.00K
$699.35
ACLX
Arcellx Inc
Apr 28, 2026
Uninformative Sell
$0.00
Savara
Jul 19, 2023
Ten Percent Owner
Informative Buy
1000.00K
$142.18M
Korro Bio
Mar 12, 2026
Director
Uninformative Buy
2.30M
$16.91M
MBX Biosciences, Inc.
Sep 17, 2024
Ten Percent Owner
Uninformative Buy
$219.31M
SpyGlass Pharma
Feb 11, 2026
Director, Ten Percent Owner
Uninformative Buy
$152.28M
List of latest transactions for each holding click on a transaction to see Ali Behbahani's performance on stock

Ali Behbahani insider profile FAQ

What is the percentage of profitable transactions made by Ali Behbahani?
The percentage of profitable transactions made by Ali Behbahani is 24%.
    What is the average return per transaction made by Ali Behbahani?
    The average return per transaction made by Ali Behbahani is -24.30%.
      What stocks does Ali Behbahani hold?
      Ali Behbahani holds: NVRO, ADAPY, GNCAQ, CRSP, RGLS, TRVI, MIRM, BDTX, OYST, AKUS, NKTX, MTCR, GLUE, CVRX, NEUE, UTRS, ACLX, SVRA, KRRO, MBX, SGP stocks.
        What was Ali Behbahani’s latest transaction?
        Ali Behbahani latest transaction was an Uninformative Buy of ―.
          What was Ali Behbahani's most profitable transaction?
          Ali Behbahani’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
            What is Ali Behbahani's role in Nevro Corp?
            Ali Behbahani's role in Nevro Corp is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.